Nocdurna

Polyuria, Nocturia, Polydipsia + 14 more
Treatment
20 Active Studies for Nocdurna

What is Nocdurna

DesmopressinThe Generic name of this drug
Treatment SummaryDesmopressin (dDAVP), is a drug that mimics a hormone made by the pituitary gland. It works by helping the body retain water, which helps to control the amount of water in the body. Desmopressin is used to treat polyuric conditions like primary nocturnal enuresis, nocturia, diabetes insipidus, mild classical hemophilia, and von Willebrand's disease. It was approved by the FDA in 1972 and is available in various forms, including intranasal solution, intravenous solution, oral tablet and oral lyophilisate. N
Ddavpis the brand name
image of different drug pills on a surface
Nocdurna Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Ddavp
Desmopressin
1978
101

Effectiveness

How Nocdurna Affects PatientsDesmopressin is a drug that acts like a natural hormone in the body, called antidiuretic hormone (ADH), to reduce urine production. It is more effective than ADH in increasing factor VIII activity in people with hemophilia and von Willebrand's disease Type I. It has a much weaker effect when taken by nasal spray instead of injection.
How Nocdurna works in the bodyWhen desmopressin binds to certain receptors in the kidneys, it triggers a series of reactions that cause more water channels to form in the kidney cells. These channels make it easier for water to pass into the cells.

When to interrupt dosage

The endorsed dose of Nocdurna is contingent upon the diagnosed condition, such as Minor Surgical Procedures, Pituitary Gland and Surgery, Hemophilia A. The quantity of dosage shifts, as per the delivery system featured in the table beneath.
Condition
Dosage
Administration
von Willebrand Disease
0.1 mg, 0.2 mg, , 0.1 mg/mL, 0.004 mg/mL, 0.0001 mg/mL, 0.01 mg, 0.06 mg, 0.12 mg, 0.24 mg, 0.025 mg, 0.05 mg, 1.5 mg/mL, 0.00083 mg, 0.00166 mg, 0.0277 mg, 0.0553 mg, 0.015 mg/mL, 0.01 mg/pump actuation, 0.15 mg/pump actuation
, Oral, Tablet, Tablet - Oral, Nasal, Solution, Solution - Nasal, Intravenous, Solution - Intravenous, Intravenous; Subcutaneous, Injection, solution, Injection, solution - Intravenous; Subcutaneous, Injection, Injection - Intravenous, Spray, Spray - Nasal, Intramuscular; Intravenous; Subcutaneous, Liquid, Liquid - Intramuscular; Intravenous; Subcutaneous, Spray, metered, Spray, metered - Nasal, Sublingual, Tablet, orally disintegrating - Sublingual, Tablet, orally disintegrating, Aerosol, metered, Aerosol, metered - Nasal, Tablet - Sublingual, Injection - Intravenous; Subcutaneous, Solution - Intramuscular; Intravenous; Subcutaneous, Solution - Intravenous; Subcutaneous
Polyuria
0.1 mg, 0.2 mg, , 0.1 mg/mL, 0.004 mg/mL, 0.0001 mg/mL, 0.01 mg, 0.06 mg, 0.12 mg, 0.24 mg, 0.025 mg, 0.05 mg, 1.5 mg/mL, 0.00083 mg, 0.00166 mg, 0.0277 mg, 0.0553 mg, 0.015 mg/mL, 0.01 mg/pump actuation, 0.15 mg/pump actuation
, Oral, Tablet, Tablet - Oral, Nasal, Solution, Solution - Nasal, Intravenous, Solution - Intravenous, Intravenous; Subcutaneous, Injection, solution, Injection, solution - Intravenous; Subcutaneous, Injection, Injection - Intravenous, Spray, Spray - Nasal, Intramuscular; Intravenous; Subcutaneous, Liquid, Liquid - Intramuscular; Intravenous; Subcutaneous, Spray, metered, Spray, metered - Nasal, Sublingual, Tablet, orally disintegrating - Sublingual, Tablet, orally disintegrating, Aerosol, metered, Aerosol, metered - Nasal, Tablet - Sublingual, Injection - Intravenous; Subcutaneous, Solution - Intramuscular; Intravenous; Subcutaneous, Solution - Intravenous; Subcutaneous
Pituitary Surgery
0.1 mg, 0.2 mg, , 0.1 mg/mL, 0.004 mg/mL, 0.0001 mg/mL, 0.01 mg, 0.06 mg, 0.12 mg, 0.24 mg, 0.025 mg, 0.05 mg, 1.5 mg/mL, 0.00083 mg, 0.00166 mg, 0.0277 mg, 0.0553 mg, 0.015 mg/mL, 0.01 mg/pump actuation, 0.15 mg/pump actuation
, Oral, Tablet, Tablet - Oral, Nasal, Solution, Solution - Nasal, Intravenous, Solution - Intravenous, Intravenous; Subcutaneous, Injection, solution, Injection, solution - Intravenous; Subcutaneous, Injection, Injection - Intravenous, Spray, Spray - Nasal, Intramuscular; Intravenous; Subcutaneous, Liquid, Liquid - Intramuscular; Intravenous; Subcutaneous, Spray, metered, Spray, metered - Nasal, Sublingual, Tablet, orally disintegrating - Sublingual, Tablet, orally disintegrating, Aerosol, metered, Aerosol, metered - Nasal, Tablet - Sublingual, Injection - Intravenous; Subcutaneous, Solution - Intramuscular; Intravenous; Subcutaneous, Solution - Intravenous; Subcutaneous
Hemophilia As
0.1 mg, 0.2 mg, , 0.1 mg/mL, 0.004 mg/mL, 0.0001 mg/mL, 0.01 mg, 0.06 mg, 0.12 mg, 0.24 mg, 0.025 mg, 0.05 mg, 1.5 mg/mL, 0.00083 mg, 0.00166 mg, 0.0277 mg, 0.0553 mg, 0.015 mg/mL, 0.01 mg/pump actuation, 0.15 mg/pump actuation
, Oral, Tablet, Tablet - Oral, Nasal, Solution, Solution - Nasal, Intravenous, Solution - Intravenous, Intravenous; Subcutaneous, Injection, solution, Injection, solution - Intravenous; Subcutaneous, Injection, Injection - Intravenous, Spray, Spray - Nasal, Intramuscular; Intravenous; Subcutaneous, Liquid, Liquid - Intramuscular; Intravenous; Subcutaneous, Spray, metered, Spray, metered - Nasal, Sublingual, Tablet, orally disintegrating - Sublingual, Tablet, orally disintegrating, Aerosol, metered, Aerosol, metered - Nasal, Tablet - Sublingual, Injection - Intravenous; Subcutaneous, Solution - Intramuscular; Intravenous; Subcutaneous, Solution - Intravenous; Subcutaneous
Uremia
0.1 mg, 0.2 mg, , 0.1 mg/mL, 0.004 mg/mL, 0.0001 mg/mL, 0.01 mg, 0.06 mg, 0.12 mg, 0.24 mg, 0.025 mg, 0.05 mg, 1.5 mg/mL, 0.00083 mg, 0.00166 mg, 0.0277 mg, 0.0553 mg, 0.015 mg/mL, 0.01 mg/pump actuation, 0.15 mg/pump actuation
, Oral, Tablet, Tablet - Oral, Nasal, Solution, Solution - Nasal, Intravenous, Solution - Intravenous, Intravenous; Subcutaneous, Injection, solution, Injection, solution - Intravenous; Subcutaneous, Injection, Injection - Intravenous, Spray, Spray - Nasal, Intramuscular; Intravenous; Subcutaneous, Liquid, Liquid - Intramuscular; Intravenous; Subcutaneous, Spray, metered, Spray, metered - Nasal, Sublingual, Tablet, orally disintegrating - Sublingual, Tablet, orally disintegrating, Aerosol, metered, Aerosol, metered - Nasal, Tablet - Sublingual, Injection - Intravenous; Subcutaneous, Solution - Intramuscular; Intravenous; Subcutaneous, Solution - Intravenous; Subcutaneous
Hemophilia
0.1 mg, 0.2 mg, , 0.1 mg/mL, 0.004 mg/mL, 0.0001 mg/mL, 0.01 mg, 0.06 mg, 0.12 mg, 0.24 mg, 0.025 mg, 0.05 mg, 1.5 mg/mL, 0.00083 mg, 0.00166 mg, 0.0277 mg, 0.0553 mg, 0.015 mg/mL, 0.01 mg/pump actuation, 0.15 mg/pump actuation
, Oral, Tablet, Tablet - Oral, Nasal, Solution, Solution - Nasal, Intravenous, Solution - Intravenous, Intravenous; Subcutaneous, Injection, solution, Injection, solution - Intravenous; Subcutaneous, Injection, Injection - Intravenous, Spray, Spray - Nasal, Intramuscular; Intravenous; Subcutaneous, Liquid, Liquid - Intramuscular; Intravenous; Subcutaneous, Spray, metered, Spray, metered - Nasal, Sublingual, Tablet, orally disintegrating - Sublingual, Tablet, orally disintegrating, Aerosol, metered, Aerosol, metered - Nasal, Tablet - Sublingual, Injection - Intravenous; Subcutaneous, Solution - Intramuscular; Intravenous; Subcutaneous, Solution - Intravenous; Subcutaneous
Primary Nocturnal Enuresis
0.1 mg, 0.2 mg, , 0.1 mg/mL, 0.004 mg/mL, 0.0001 mg/mL, 0.01 mg, 0.06 mg, 0.12 mg, 0.24 mg, 0.025 mg, 0.05 mg, 1.5 mg/mL, 0.00083 mg, 0.00166 mg, 0.0277 mg, 0.0553 mg, 0.015 mg/mL, 0.01 mg/pump actuation, 0.15 mg/pump actuation
, Oral, Tablet, Tablet - Oral, Nasal, Solution, Solution - Nasal, Intravenous, Solution - Intravenous, Intravenous; Subcutaneous, Injection, solution, Injection, solution - Intravenous; Subcutaneous, Injection, Injection - Intravenous, Spray, Spray - Nasal, Intramuscular; Intravenous; Subcutaneous, Liquid, Liquid - Intramuscular; Intravenous; Subcutaneous, Spray, metered, Spray, metered - Nasal, Sublingual, Tablet, orally disintegrating - Sublingual, Tablet, orally disintegrating, Aerosol, metered, Aerosol, metered - Nasal, Tablet - Sublingual, Injection - Intravenous; Subcutaneous, Solution - Intramuscular; Intravenous; Subcutaneous, Solution - Intravenous; Subcutaneous
Hemorrhage
0.1 mg, 0.2 mg, , 0.1 mg/mL, 0.004 mg/mL, 0.0001 mg/mL, 0.01 mg, 0.06 mg, 0.12 mg, 0.24 mg, 0.025 mg, 0.05 mg, 1.5 mg/mL, 0.00083 mg, 0.00166 mg, 0.0277 mg, 0.0553 mg, 0.015 mg/mL, 0.01 mg/pump actuation, 0.15 mg/pump actuation
, Oral, Tablet, Tablet - Oral, Nasal, Solution, Solution - Nasal, Intravenous, Solution - Intravenous, Intravenous; Subcutaneous, Injection, solution, Injection, solution - Intravenous; Subcutaneous, Injection, Injection - Intravenous, Spray, Spray - Nasal, Intramuscular; Intravenous; Subcutaneous, Liquid, Liquid - Intramuscular; Intravenous; Subcutaneous, Spray, metered, Spray, metered - Nasal, Sublingual, Tablet, orally disintegrating - Sublingual, Tablet, orally disintegrating, Aerosol, metered, Aerosol, metered - Nasal, Tablet - Sublingual, Injection - Intravenous; Subcutaneous, Solution - Intramuscular; Intravenous; Subcutaneous, Solution - Intravenous; Subcutaneous
Nocturia
0.1 mg, 0.2 mg, , 0.1 mg/mL, 0.004 mg/mL, 0.0001 mg/mL, 0.01 mg, 0.06 mg, 0.12 mg, 0.24 mg, 0.025 mg, 0.05 mg, 1.5 mg/mL, 0.00083 mg, 0.00166 mg, 0.0277 mg, 0.0553 mg, 0.015 mg/mL, 0.01 mg/pump actuation, 0.15 mg/pump actuation
, Oral, Tablet, Tablet - Oral, Nasal, Solution, Solution - Nasal, Intravenous, Solution - Intravenous, Intravenous; Subcutaneous, Injection, solution, Injection, solution - Intravenous; Subcutaneous, Injection, Injection - Intravenous, Spray, Spray - Nasal, Intramuscular; Intravenous; Subcutaneous, Liquid, Liquid - Intramuscular; Intravenous; Subcutaneous, Spray, metered, Spray, metered - Nasal, Sublingual, Tablet, orally disintegrating - Sublingual, Tablet, orally disintegrating, Aerosol, metered, Aerosol, metered - Nasal, Tablet - Sublingual, Injection - Intravenous; Subcutaneous, Solution - Intramuscular; Intravenous; Subcutaneous, Solution - Intravenous; Subcutaneous
Polyuria
0.1 mg, 0.2 mg, , 0.1 mg/mL, 0.004 mg/mL, 0.0001 mg/mL, 0.01 mg, 0.06 mg, 0.12 mg, 0.24 mg, 0.025 mg, 0.05 mg, 1.5 mg/mL, 0.00083 mg, 0.00166 mg, 0.0277 mg, 0.0553 mg, 0.015 mg/mL, 0.01 mg/pump actuation, 0.15 mg/pump actuation
, Oral, Tablet, Tablet - Oral, Nasal, Solution, Solution - Nasal, Intravenous, Solution - Intravenous, Intravenous; Subcutaneous, Injection, solution, Injection, solution - Intravenous; Subcutaneous, Injection, Injection - Intravenous, Spray, Spray - Nasal, Intramuscular; Intravenous; Subcutaneous, Liquid, Liquid - Intramuscular; Intravenous; Subcutaneous, Spray, metered, Spray, metered - Nasal, Sublingual, Tablet, orally disintegrating - Sublingual, Tablet, orally disintegrating, Aerosol, metered, Aerosol, metered - Nasal, Tablet - Sublingual, Injection - Intravenous; Subcutaneous, Solution - Intramuscular; Intravenous; Subcutaneous, Solution - Intravenous; Subcutaneous
Polydipsia
0.1 mg, 0.2 mg, , 0.1 mg/mL, 0.004 mg/mL, 0.0001 mg/mL, 0.01 mg, 0.06 mg, 0.12 mg, 0.24 mg, 0.025 mg, 0.05 mg, 1.5 mg/mL, 0.00083 mg, 0.00166 mg, 0.0277 mg, 0.0553 mg, 0.015 mg/mL, 0.01 mg/pump actuation, 0.15 mg/pump actuation
, Oral, Tablet, Tablet - Oral, Nasal, Solution, Solution - Nasal, Intravenous, Solution - Intravenous, Intravenous; Subcutaneous, Injection, solution, Injection, solution - Intravenous; Subcutaneous, Injection, Injection - Intravenous, Spray, Spray - Nasal, Intramuscular; Intravenous; Subcutaneous, Liquid, Liquid - Intramuscular; Intravenous; Subcutaneous, Spray, metered, Spray, metered - Nasal, Sublingual, Tablet, orally disintegrating - Sublingual, Tablet, orally disintegrating, Aerosol, metered, Aerosol, metered - Nasal, Tablet - Sublingual, Injection - Intravenous; Subcutaneous, Solution - Intramuscular; Intravenous; Subcutaneous, Solution - Intravenous; Subcutaneous
von Willebrand Disease
0.1 mg, 0.2 mg, , 0.1 mg/mL, 0.004 mg/mL, 0.0001 mg/mL, 0.01 mg, 0.06 mg, 0.12 mg, 0.24 mg, 0.025 mg, 0.05 mg, 1.5 mg/mL, 0.00083 mg, 0.00166 mg, 0.0277 mg, 0.0553 mg, 0.015 mg/mL, 0.01 mg/pump actuation, 0.15 mg/pump actuation
, Oral, Tablet, Tablet - Oral, Nasal, Solution, Solution - Nasal, Intravenous, Solution - Intravenous, Intravenous; Subcutaneous, Injection, solution, Injection, solution - Intravenous; Subcutaneous, Injection, Injection - Intravenous, Spray, Spray - Nasal, Intramuscular; Intravenous; Subcutaneous, Liquid, Liquid - Intramuscular; Intravenous; Subcutaneous, Spray, metered, Spray, metered - Nasal, Sublingual, Tablet, orally disintegrating - Sublingual, Tablet, orally disintegrating, Aerosol, metered, Aerosol, metered - Nasal, Tablet - Sublingual, Injection - Intravenous; Subcutaneous, Solution - Intramuscular; Intravenous; Subcutaneous, Solution - Intravenous; Subcutaneous
Surgery, Hemophilia A
0.1 mg, 0.2 mg, , 0.1 mg/mL, 0.004 mg/mL, 0.0001 mg/mL, 0.01 mg, 0.06 mg, 0.12 mg, 0.24 mg, 0.025 mg, 0.05 mg, 1.5 mg/mL, 0.00083 mg, 0.00166 mg, 0.0277 mg, 0.0553 mg, 0.015 mg/mL, 0.01 mg/pump actuation, 0.15 mg/pump actuation
, Oral, Tablet, Tablet - Oral, Nasal, Solution, Solution - Nasal, Intravenous, Solution - Intravenous, Intravenous; Subcutaneous, Injection, solution, Injection, solution - Intravenous; Subcutaneous, Injection, Injection - Intravenous, Spray, Spray - Nasal, Intramuscular; Intravenous; Subcutaneous, Liquid, Liquid - Intramuscular; Intravenous; Subcutaneous, Spray, metered, Spray, metered - Nasal, Sublingual, Tablet, orally disintegrating - Sublingual, Tablet, orally disintegrating, Aerosol, metered, Aerosol, metered - Nasal, Tablet - Sublingual, Injection - Intravenous; Subcutaneous, Solution - Intramuscular; Intravenous; Subcutaneous, Solution - Intravenous; Subcutaneous
pituitary trauma
0.1 mg, 0.2 mg, , 0.1 mg/mL, 0.004 mg/mL, 0.0001 mg/mL, 0.01 mg, 0.06 mg, 0.12 mg, 0.24 mg, 0.025 mg, 0.05 mg, 1.5 mg/mL, 0.00083 mg, 0.00166 mg, 0.0277 mg, 0.0553 mg, 0.015 mg/mL, 0.01 mg/pump actuation, 0.15 mg/pump actuation
, Oral, Tablet, Tablet - Oral, Nasal, Solution, Solution - Nasal, Intravenous, Solution - Intravenous, Intravenous; Subcutaneous, Injection, solution, Injection, solution - Intravenous; Subcutaneous, Injection, Injection - Intravenous, Spray, Spray - Nasal, Intramuscular; Intravenous; Subcutaneous, Liquid, Liquid - Intramuscular; Intravenous; Subcutaneous, Spray, metered, Spray, metered - Nasal, Sublingual, Tablet, orally disintegrating - Sublingual, Tablet, orally disintegrating, Aerosol, metered, Aerosol, metered - Nasal, Tablet - Sublingual, Injection - Intravenous; Subcutaneous, Solution - Intramuscular; Intravenous; Subcutaneous, Solution - Intravenous; Subcutaneous
Hemorrhage
0.1 mg, 0.2 mg, , 0.1 mg/mL, 0.004 mg/mL, 0.0001 mg/mL, 0.01 mg, 0.06 mg, 0.12 mg, 0.24 mg, 0.025 mg, 0.05 mg, 1.5 mg/mL, 0.00083 mg, 0.00166 mg, 0.0277 mg, 0.0553 mg, 0.015 mg/mL, 0.01 mg/pump actuation, 0.15 mg/pump actuation
, Oral, Tablet, Tablet - Oral, Nasal, Solution, Solution - Nasal, Intravenous, Solution - Intravenous, Intravenous; Subcutaneous, Injection, solution, Injection, solution - Intravenous; Subcutaneous, Injection, Injection - Intravenous, Spray, Spray - Nasal, Intramuscular; Intravenous; Subcutaneous, Liquid, Liquid - Intramuscular; Intravenous; Subcutaneous, Spray, metered, Spray, metered - Nasal, Sublingual, Tablet, orally disintegrating - Sublingual, Tablet, orally disintegrating, Aerosol, metered, Aerosol, metered - Nasal, Tablet - Sublingual, Injection - Intravenous; Subcutaneous, Solution - Intramuscular; Intravenous; Subcutaneous, Solution - Intravenous; Subcutaneous
Central Diabetes Insipidus
0.1 mg, 0.2 mg, , 0.1 mg/mL, 0.004 mg/mL, 0.0001 mg/mL, 0.01 mg, 0.06 mg, 0.12 mg, 0.24 mg, 0.025 mg, 0.05 mg, 1.5 mg/mL, 0.00083 mg, 0.00166 mg, 0.0277 mg, 0.0553 mg, 0.015 mg/mL, 0.01 mg/pump actuation, 0.15 mg/pump actuation
, Oral, Tablet, Tablet - Oral, Nasal, Solution, Solution - Nasal, Intravenous, Solution - Intravenous, Intravenous; Subcutaneous, Injection, solution, Injection, solution - Intravenous; Subcutaneous, Injection, Injection - Intravenous, Spray, Spray - Nasal, Intramuscular; Intravenous; Subcutaneous, Liquid, Liquid - Intramuscular; Intravenous; Subcutaneous, Spray, metered, Spray, metered - Nasal, Sublingual, Tablet, orally disintegrating - Sublingual, Tablet, orally disintegrating, Aerosol, metered, Aerosol, metered - Nasal, Tablet - Sublingual, Injection - Intravenous; Subcutaneous, Solution - Intramuscular; Intravenous; Subcutaneous, Solution - Intravenous; Subcutaneous
Minor Surgical Procedures
0.1 mg, 0.2 mg, , 0.1 mg/mL, 0.004 mg/mL, 0.0001 mg/mL, 0.01 mg, 0.06 mg, 0.12 mg, 0.24 mg, 0.025 mg, 0.05 mg, 1.5 mg/mL, 0.00083 mg, 0.00166 mg, 0.0277 mg, 0.0553 mg, 0.015 mg/mL, 0.01 mg/pump actuation, 0.15 mg/pump actuation
, Oral, Tablet, Tablet - Oral, Nasal, Solution, Solution - Nasal, Intravenous, Solution - Intravenous, Intravenous; Subcutaneous, Injection, solution, Injection, solution - Intravenous; Subcutaneous, Injection, Injection - Intravenous, Spray, Spray - Nasal, Intramuscular; Intravenous; Subcutaneous, Liquid, Liquid - Intramuscular; Intravenous; Subcutaneous, Spray, metered, Spray, metered - Nasal, Sublingual, Tablet, orally disintegrating - Sublingual, Tablet, orally disintegrating, Aerosol, metered, Aerosol, metered - Nasal, Tablet - Sublingual, Injection - Intravenous; Subcutaneous, Solution - Intramuscular; Intravenous; Subcutaneous, Solution - Intravenous; Subcutaneous

Warnings

Nocdurna Contraindications
Condition
Risk Level
Notes
history of hyponatremia
Do Not Combine
Renal Insufficiency
Do Not Combine
Hyponatremia
Do Not Combine
There are 20 known major drug interactions with Nocdurna.
Common Nocdurna Drug Interactions
Drug Name
Risk Level
Description
1-benzylimidazole
Minor
The risk or severity of hypertension can be increased when Desmopressin is combined with 1-benzylimidazole.
2,5-Dimethoxy-4-ethylamphetamine
Minor
The risk or severity of hypertension can be increased when Desmopressin is combined with 2,5-Dimethoxy-4-ethylamphetamine.
2,5-Dimethoxy-4-ethylthioamphetamine
Minor
The risk or severity of hypertension can be increased when Desmopressin is combined with 2,5-Dimethoxy-4-ethylthioamphetamine.
4-Bromo-2,5-dimethoxyamphetamine
Minor
The risk or severity of hypertension can be increased when Desmopressin is combined with 4-Bromo-2,5-dimethoxyamphetamine.
4-Methoxyamphetamine
Minor
The risk or severity of hypertension can be increased when Desmopressin is combined with 4-Methoxyamphetamine.
Nocdurna Toxicity & Overdose RiskThe lowest toxic dose of desmopressin in humans is 0.3 µg/kg/10M. Overdosing on desmopressin can lead to low levels of sodium in the blood, which can cause seizures, confusion, drowsiness, headaches, heart rhythm problems, and swelling. If an overdose occurs, the dose or frequency of the drug should be reduced or stopped. Checking the levels of sodium in the blood and seeking medical treatment is also recommended.
image of a doctor in a lab doing drug, clinical research

Nocdurna Novel Uses: Which Conditions Have a Clinical Trial Featuring Nocdurna?

Currently, 30 active trials are being conducted to assess the potential of Nocdurna in providing relief from Polyuria, Hemophilia A and Hemophilia B.
Condition
Clinical Trials
Trial Phases
Surgery, Hemophilia A
0 Actively Recruiting
Polyuria
0 Actively Recruiting
Polydipsia
0 Actively Recruiting
Uremia
0 Actively Recruiting
pituitary trauma
0 Actively Recruiting
Polyuria
0 Actively Recruiting
Nocturia
6 Actively Recruiting
Phase 4, Not Applicable
Hemorrhage
13 Actively Recruiting
Phase 4, Phase 3, Not Applicable, Phase 1, Phase 2
Hemophilia
4 Actively Recruiting
Phase 3
von Willebrand Disease
2 Actively Recruiting
Phase 3
von Willebrand Disease
0 Actively Recruiting
Primary Nocturnal Enuresis
0 Actively Recruiting
Hemorrhage
0 Actively Recruiting
Minor Surgical Procedures
0 Actively Recruiting
Central Diabetes Insipidus
1 Actively Recruiting
Phase 1
Pituitary Surgery
0 Actively Recruiting
Hemophilia As
3 Actively Recruiting
Phase 3

Nocdurna Reviews: What are patients saying about Nocdurna?

3Patient Review
11/28/2021
Nocdurna for Urination During the Night
Nocdurna has helped me a lot. I used to wake up 12 times per night, and now it's more like 2-6.
2.7Patient Review
10/31/2019
Nocdurna for Urination During the Night
1.7Patient Review
8/5/2020
Nocdurna for Urination During the Night
Despite being able to afford the medication, it has not been effective in reducing my frequency. I'm very disappointed after 4 months of use.
1Patient Review
9/8/2021
Nocdurna for Urination During the Night
Ineffective and did not provide any relief.
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about nocdurna

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is Nocdurna used for?

"NOCDURNA is used to help reduce the number of times you wake up at night to urinate due to nocturnal polyuria."

Answered by AI

How long does it take for Nocdurna to work?

"Antidiuretic hormone (ADH) helps the kidneys to produce less urine. NOCDURNA, on average, starts working within 30 minutes after you take it."

Answered by AI

Who manufactures Nocdurna?

"The FDA has approved NOCDURNA, the first sublingual tablet for the treatment of nocturia due to nocturnal polyuria in adults. NOCDURNA is taken before bedtime and dissolves under the tongue to help reduce the number of times you need to wake up at night to go to the bathroom."

Answered by AI

Is there a generic for Nocdurna?

"At this time, there are no drugs that are the same as Nocdurna, but not under the same name."

Answered by AI

Clinical Trials for Nocdurna

Have you considered Nocdurna clinical trials? We made a collection of clinical trials featuring Nocdurna, we think they might fit your search criteria.
Have you considered Nocdurna clinical trials? We made a collection of clinical trials featuring Nocdurna, we think they might fit your search criteria.
Have you considered Nocdurna clinical trials? We made a collection of clinical trials featuring Nocdurna, we think they might fit your search criteria.